Tuberculosis & HIV/AIDS: Treatment
- Researchers Discuss Advances in Tuberculosis Treatment (March 11, 2013)
From HIVandHepatitis.com
- TB: CDC Encourages Docs to Check for Antibiotic Resistance (December 5, 2012)
In CATIE News, from Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- An Overview of Rifampin (Rifadin, Rimactane) (October 2, 2012)
From AIDSinfo
- Efavirenz Interaction Studies With TB Compounds Bedaquiline and Delamanid (September/October 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Experimental Nitroimidazole TBA-354 Shows Promise Against Tuberculosis in Early Studies (September 11, 2012)
From HIVandHepatitis.com
- Need for Expanded Access to Two Promising MDR TB Drugs (January/February 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- HHS Guidelines Panels Issue Statement on Treating Latent Tuberculosis Infection in People Infected With HIV Receiving Antiretroviral Therapy (December 20, 2011)
Short-course (3-month) therapy with weekly isoniazid-rifapentine is NOT RECOMMENDED for HIV-infected patients receiving antiretroviral therapy.
From AIDSinfo
- Earlier Versus Later Start of Antiretroviral Therapy in HIV-Infected Adults With Tuberculosis (October 31, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- AstraZeneca Joins Rival to Develop New TB Treatment (March 15, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The First New Tuberculosis Drug in Decades: Promise and Challenges (Winter 2011)
To read PDF, click here.
In TAGline, from Treatment Action Group
On TheBodyPRO.com
VIEW ALL ARTICLES
|
Advertisement
|